SM
ACOR

Salzhauer Michael’s Acorda Therapeutics ACOR Stock Holding History

Salzhauer Michael’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-220
Closed -$18K – 123
2020
Q4 		$18K Hold
220
– – 0.01% 103
2020
Q3 		$14K Hold
220
– – 0.02% 91
2020
Q2 		$19K Sell
220
-30
-12% -$3.17K 0.02% 79
2020
Q1 		$28K Buy
+250
New +$49.2K 0.05% 98

Other funds holding ACOR

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
CCA
Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Salzhauer Michael's ACOR Position: Q1 2021 in Review

Salzhauer Michael sold out of Acorda Therapeutics (ACOR) in Q1 2021, closing a stake of 220 shares — an estimated $18K sold.

Salzhauer Michael first reported a position in ACOR in Q1 2020 and held it in 4 quarters. The position peaked at $28K in Q1 2020. 32 funds tracked by Wall St. Rank hold ACOR as of Q1 2021.

  • Salzhauer Michael reported no remaining Acorda Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Salzhauer Michael sold 220 Acorda Therapeutics shares in Q1 2021, an estimated $18K.
  • Salzhauer Michael first reported a position in Acorda Therapeutics in Q1 2020 and held it in 4 quarters.
  • Salzhauer Michael's Acorda Therapeutics position peaked at $28K in Q1 2020.
  • 32 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2021.

Based on Salzhauer Michael's 13F filing for Q1 2021, filed 12 May 2021.